Population-basedscreening with the PSA test has decreased PCa mortality; however,due to the test’s relatively poor specificity, it has alsoincreased the detection of indolent cancers and resulted in overtreatmentof patients. This evidence concerns the gene KLK3 and posterior cortical atrophy.